Fariba Navid

5.6k total citations
104 papers, 2.8k citations indexed

About

Fariba Navid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Fariba Navid has authored 104 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Fariba Navid's work include Sarcoma Diagnosis and Treatment (41 papers), Neuroblastoma Research and Treatments (22 papers) and Cancer therapeutics and mechanisms (10 papers). Fariba Navid is often cited by papers focused on Sarcoma Diagnosis and Treatment (41 papers), Neuroblastoma Research and Treatments (22 papers) and Cancer therapeutics and mechanisms (10 papers). Fariba Navid collaborates with scholars based in United States, Germany and Canada. Fariba Navid's co-authors include Victor M. Santana, Najat C. Daw, Catherine A. Billups, Jianrong Wu, M. Beth McCarville, Matthew J. Krasin, Carlos Rodríguez‐Galindo, Wayne L. Furman, Raymond Barfield and Bhaskar N. Rao and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Fariba Navid

101 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fariba Navid United States 31 1.3k 896 686 538 416 104 2.8k
Cynthia E. Herzog United States 32 1.1k 0.9× 1.0k 1.1× 617 0.9× 366 0.7× 625 1.5× 91 2.7k
Noah Federman United States 28 1.3k 1.0× 1.0k 1.1× 845 1.2× 355 0.7× 295 0.7× 142 3.0k
Sandra J. Strauss United Kingdom 30 1.5k 1.1× 1.3k 1.4× 844 1.2× 250 0.5× 261 0.6× 94 3.1k
Alexander J. Chou United States 25 1.1k 0.9× 726 0.8× 931 1.4× 229 0.4× 241 0.6× 61 2.4k
Federica Grosso Italy 33 3.0k 2.3× 1.8k 2.0× 642 0.9× 330 0.6× 535 1.3× 158 4.4k
Lars M. Wagner United States 29 845 0.6× 707 0.8× 1.1k 1.6× 686 1.3× 237 0.6× 82 2.4k
Katherine A. Janeway United States 35 2.1k 1.6× 1.1k 1.2× 1.5k 2.1× 762 1.4× 686 1.6× 148 4.5k
Andreas Schuck Germany 25 1.8k 1.4× 446 0.5× 458 0.7× 250 0.5× 615 1.5× 63 2.7k
Flavio Crippa Italy 30 1.1k 0.8× 1.1k 1.2× 340 0.5× 209 0.4× 729 1.8× 124 3.2k
Makoto Sonobe Japan 36 2.8k 2.1× 1.5k 1.7× 780 1.1× 1.0k 1.9× 779 1.9× 224 4.8k

Countries citing papers authored by Fariba Navid

Since Specialization
Citations

This map shows the geographic impact of Fariba Navid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariba Navid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariba Navid more than expected).

Fields of papers citing papers by Fariba Navid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariba Navid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariba Navid. The network helps show where Fariba Navid may publish in the future.

Co-authorship network of co-authors of Fariba Navid

This figure shows the co-authorship network connecting the top 25 collaborators of Fariba Navid. A scholar is included among the top collaborators of Fariba Navid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariba Navid. Fariba Navid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grohar, Patrick J., Karla V. Ballman, Leo Mascarenhas, et al.. (2024). SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).. Journal of Clinical Oncology. 42(16_suppl). 11508–11508. 5 indexed citations
2.
Buckley, Jonathan D., Ryan J. Schmidt, Dejerianne Ostrow, et al.. (2023). An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors. Journal of Molecular Diagnostics. 26(2). 127–139. 3 indexed citations
3.
Malvar, Jemily, Yueh‐Yun Chi, Eugene S. Kim, et al.. (2023). Survival outcomes and surgical morbidity based on surgical approach to pulmonary metastasectomy in pediatric, adolescent and young adult patients with osteosarcoma. Cancer Medicine. 12(20). 20231–20241. 6 indexed citations
4.
Navid, Fariba, et al.. (2022). The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors. Pediatric Drugs. 24(5). 433–445. 1 indexed citations
5.
Warren, Mikako, Jemily Malvar, Joseph M. Miller, et al.. (2021). Kaposiform hemangioendothelioma of the bone in children and adolescents. Pediatric Blood & Cancer. 69(1). e29392–e29392. 7 indexed citations
6.
Sparber‐Sauer, Monika, Daniel Orbach, Fariba Navid, et al.. (2021). Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. British Journal of Cancer. 124(10). 1637–1646. 18 indexed citations
7.
Inaba, Hiroto, John C. Panetta, Stanley Pounds, et al.. (2019). Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies. Clinical Cancer Research. 25(24). 7320–7330. 15 indexed citations
8.
Ji, Jianling, Fariba Navid, Maki Kaneko, et al.. (2018). Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant. Cancer Genetics. 231-232. 62–66. 7 indexed citations
9.
Morris, Zachary S., David M. Francis, Lauryn R. Werner, et al.. (2016). In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Research. 76(13). 3929–3941. 119 indexed citations
10.
Interiano, Rodrigo B., et al.. (2015). Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors. Journal of Pediatric Surgery. 50(9). 1484–1489. 30 indexed citations
11.
Guo, Junyu, John O. Glass, M. Beth McCarville, et al.. (2015). Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. British Journal of Cancer. 113(9). 1282–1288. 26 indexed citations
12.
Turner, David C., Fariba Navid, Najat C. Daw, et al.. (2014). Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing. Clinical Cancer Research. 20(10). 2783–2792. 40 indexed citations
13.
Alderson, Kory L., et al.. (2012). Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG. Cancer Immunology Immunotherapy. 62(4). 665–675. 21 indexed citations
14.
Fernández‐Pineda, Israel, Fariba Navid, Andrew M. Davidoff, et al.. (2012). Clinical management of Ewing sarcoma of the bones of the hands and feet: a retrospective single-institution review. Journal of Pediatric Surgery. 47(10). 1806–1810. 8 indexed citations
15.
Pappo, Alberto S., et al.. (2012). Management of Melanomas in Children and Young Adults. Journal of Pediatric Hematology/Oncology. 34(Supplement 2). S51–S54. 20 indexed citations
16.
Tagen, Michael, et al.. (2010). Stability of Cyclophosphamide in Extemporaneous Oral Suspensions. Annals of Pharmacotherapy. 44(2). 295–301. 15 indexed citations
17.
Furman, Wayne L., Fariba Navid, Najat C. Daw, et al.. (2009). Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 27(27). 4599–4604. 42 indexed citations
18.
Rodríguez‐Galindo, Carlos, et al.. (2007). Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Annals of Oncology. 19(4). 814–820. 107 indexed citations
19.
Saab, Raya, Joseph D. Khoury, Matthew J. Krasin, Andrew M. Davidoff, & Fariba Navid. (2006). Desmoplastic small round cell tumor in childhood: The St. Jude Children's Research Hospital experience. Pediatric Blood & Cancer. 49(3). 274–279. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia E. Herzog Breakdown of academic impact, for papers by Noah Federman Breakdown of academic impact, for papers by Sandra J. Strauss Breakdown of academic impact, for papers by Alexander J. Chou Breakdown of academic impact, for papers by Federica Grosso Breakdown of academic impact, for papers by Lars M. Wagner Breakdown of academic impact, for papers by Katherine A. Janeway Breakdown of academic impact, for papers by Andreas Schuck Breakdown of academic impact, for papers by Flavio Crippa Breakdown of academic impact, for papers by Makoto Sonobe
Rankless by CCL
2026